Triple-negative breast cancer (TNBC) represents a distinct subtype of breast cancer (BC) characterized by the lack of expression of estrogen receptor (ER) and progesterone receptor (PR), and the absence of human epidermal growth factor receptor 2 (HER2) amplification [1]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.